CGCNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends March 31
Canopy Growth Corp
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$0.72+0.00 (+0.38%)
Close on Oct 19, 2026
Canopy Growth Corp revenue by segment
By business segment
| Revenue | TTM Q1 27 | TTM Q4 26 | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cannabis Net Revenue | C$222.05M | C$213.94M | C$204.99M | C$203.04M | C$197.62M | C$186.73M | – | – | – | – | – | – | 75.6% | +12.4% |
| Storz & Bickel | C$71.59M | C$70.66M | C$73.40M | C$75.57M | C$77.30M | C$82.27M | C$93.69M | C$87.09M | C$81.51M | C$79.46M | C$64.01M | C$65.77M | 24.4% | -7.4% |
| Canadian adult-use Cannabis Net Revenue | – | – | – | – | – | – | – | – | – | C$92.37M | C$93.24M | C$102.41M | – | – |
| Canadian Medical Cannabis Net Revenue | – | – | – | – | – | – | – | – | – | C$61.35M | C$59.13M | C$57.54M | – | – |
| Rest-of-world Cannabis | – | – | – | – | – | – | – | – | – | – | C$38.44M | C$33.76M | – | – |
| This Works | – | – | – | – | – | – | – | – | – | C$21.26M | C$26.61M | C$26.73M | – | – |
| Other | – | – | – | – | – | – | – | – | – | C$4.74M | C$7.26M | C$10.17M | – | – |
| Canadian Cannabis Net Revenue | – | – | – | – | – | C$155.86M | C$154.11M | C$153.76M | C$156.95M | C$159.17M | C$164.65M | C$170.89M | – | – |
| Canada Cannabis | – | – | C$122.84M | C$120.89M | C$115.47M | C$155.86M | C$179.84M | C$170.52M | C$165.37M | C$159.17M | C$164.65M | C$170.89M | – | – |
| International Markets Cannabis | – | – | – | – | – | C$39.73M | C$43.81M | C$42.32M | C$41.23M | C$41.31M | – | – | – | – |
By product or service
| Revenue | TTM Q1 27 | TTM Q4 26 | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Storz & Bickel | C$71.59M | C$70.66M | C$73.40M | C$75.57M | C$77.30M | C$82.27M | C$93.69M | C$87.09M | C$81.51M | C$79.46M | C$64.01M | C$65.77M | 24.4% | -7.4% |
| International Markets Cannabis | C$29.50M | C$28.65M | C$25.19M | C$27.95M | C$31.21M | C$30.87M | C$28.59M | C$30.14M | C$30.77M | C$32.52M | – | – | 10.0% | -5.5% |
| This Work | – | – | – | – | – | – | – | – | – | C$21.26M | C$26.61M | C$26.73M | – | – |
| Other | – | – | – | – | – | – | – | – | – | C$4.74M | C$7.26M | C$10.17M | – | – |
By region
| Revenue | TTM Q1 27 | TTM Q4 26 | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Canada | C$192.80M | C$186.09M | C$179.86M | C$175.15M | C$166.46M | C$155.91M | C$154.47M | C$154.77M | C$158.86M | C$162.71M | C$162.14M | C$171.45M | 65.7% | +15.8% |
| Germany | C$65.28M | C$62.07M | C$58.75M | C$57.29M | C$58.77M | C$59.90M | C$64.36M | C$60.09M | C$55.96M | C$52.19M | C$47.61M | C$46.92M | 22.2% | +11.1% |
| United States | C$28.53M | C$28.27M | C$29.49M | C$32.38M | C$33.35M | C$35.99M | C$40.40M | C$39.18M | C$37.96M | C$40.99M | C$34.71M | C$33.82M | 9.7% | -14.5% |
| Other | C$7.02M | C$8.17M | C$10.29M | C$13.80M | C$16.34M | C$17.19M | C$17.52M | C$26.47M | C$34.32M | C$41.25M | C$48.14M | C$46.75M | 2.4% | -57.0% |
From the segment and revenue-disaggregation notes of Canopy Growth's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.